The Nanochannel Delivery System for Constant Testosterone Replacement Therapy

Abstract

In conclusion, we demonstrate that nDS-F1 implants represents a novel approach for the treatment of male hypogonadism. Further studies will be performed in view of translating the technology to clinical use.